Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.56 USD | +3.75% | +12.55% | +65.71% |
May. 15 | B. Riley Raises Price Target on Harrow Health to $29 From $26, Keeps Buy Rating | MT |
May. 14 | Transcript : Harrow, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+63.57% | 633M | |
+37.78% | 727B | |
-7.92% | 354B | |
+15.55% | 328B | |
-0.45% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+3.94% | 164B | |
-2.07% | 164B |
- Stock Market
- Equities
- HROW Stock
- News Harrow, Inc.
- B. Riley Raises Harrow Health's PT to $45 From $42 on Heels of Announced Transactions With Santen, Novaliq; Keeps Buy Rating